IRIS - Res&Arch Institutional Research Information System - Research & Archive

MORETTI, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.269
EU - Europa 1.537
AS - Asia 1.290
SA - Sud America 220
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 21
OC - Oceania 3
Totale 5.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.208
SG - Singapore 553
UA - Ucraina 278
IT - Italia 201
CN - Cina 195
SE - Svezia 195
IE - Irlanda 180
FR - Francia 179
BR - Brasile 173
HK - Hong Kong 154
RU - Federazione Russa 149
DE - Germania 128
VN - Vietnam 112
KR - Corea 88
FI - Finlandia 75
GB - Regno Unito 57
BD - Bangladesh 54
IN - India 28
CA - Canada 23
IQ - Iraq 17
BE - Belgio 16
PK - Pakistan 16
AR - Argentina 13
RO - Romania 13
AT - Austria 12
MX - Messico 12
TR - Turchia 12
PL - Polonia 11
CH - Svizzera 10
NL - Olanda 10
SA - Arabia Saudita 10
CO - Colombia 9
ID - Indonesia 7
UZ - Uzbekistan 7
EC - Ecuador 6
JP - Giappone 6
CR - Costa Rica 5
EU - Europa 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
ES - Italia 4
GR - Grecia 4
GT - Guatemala 4
LB - Libano 4
MY - Malesia 4
UY - Uruguay 4
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CW - ???statistics.table.value.countryCode.CW??? 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
JO - Giordania 1
LK - Sri Lanka 1
LR - Liberia 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
Totale 5.347
Salva come PNG Salva come JPEG
Città #
Singapore 386
Chandler 276
San Jose 212
Ashburn 181
Dublin 180
Hong Kong 154
Jacksonville 152
San Mateo 100
Santa Clara 89
Boardman 72
Ann Arbor 69
Seoul 69
Council Bluffs 68
Dong Ket 66
Beijing 57
Munich 56
Medford 52
Moscow 49
Princeton 49
Lauterbourg 45
Altamura 43
Wilmington 43
Andover 33
Dallas 32
New York 32
Perugia 32
Lawrence 31
Los Angeles 29
Piscataway 26
Redmond 19
The Dalles 19
Turku 19
São Paulo 18
Brussels 16
Woodbridge 16
Ho Chi Minh City 14
Auburn Hills 13
Rome 13
Bucharest 12
Orem 11
Chicago 10
Falls Church 10
Helsinki 10
Phoenix 10
Hanoi 9
London 9
Naples 9
Shanghai 9
Chennai 8
Milan 8
Saint Petersburg 8
Norwalk 7
Warsaw 7
Atlanta 6
North Bergen 6
Redwood City 6
Rio de Janeiro 6
Tashkent 6
Tokyo 6
Toronto 6
Baghdad 5
Brasília 5
Brooklyn 5
Columbus 5
Des Moines 5
Falkenstein 5
Guangzhou 5
Lahore 5
Nuremberg 5
Philadelphia 5
Stockholm 5
Vienna 5
Buffalo 4
Charlotte 4
Columbia 4
Curitiba 4
Dammam 4
Den Haag 4
Frankfurt am Main 4
Izmir 4
Lausanne 4
Manaus 4
Montreal 4
San José 4
San Paolo di Civitate 4
Seattle 4
Washington 4
Amsterdam 3
Belo Horizonte 3
Bogotá 3
Da Nang 3
Denver 3
Hyderabad 3
Karbala 3
Limeira 3
Manchester 3
Medellín 3
Montevideo 3
Piracicaba 3
Quito 3
Totale 3.168
Salva come PNG Salva come JPEG
Nome #
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 163
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF). 161
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 158
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 144
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 141
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. 140
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 140
Analisi del meccanismo dominante inibitorio esercitato in cis dalle mutazioni inattivanti D594V e G596R sulla mutazione attivante di BRAF V600E 136
Search of ret/ptc rearrangement and braf and ras mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of braf mutation and allowed to detect a new mutation of braf oncoprotein 133
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. 126
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer 125
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 124
Etiopatogenesi dei carcinomi della tiroide che originano dall’epitelio follicolare 123
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 119
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 118
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 117
Medicina molecolare in chirurgia della tiroide 116
Caratterizzazione biochimica e molecolare della nuova mutazione BRAFV599Ins recentemente individuata in un carcinoma papillare della tiroide 116
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer 115
Molecular dynamic simulations of the catalytic domain of BRAF in response to activating and inactivating mutations 114
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation 112
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 112
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. 110
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 106
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 105
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 105
Braf mutation testing in fnac samples increases accuracy of thyroid cytology in a region of high braf mutation prevalence 102
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors. 101
Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 98
Le sostituzioni aminoacidiche G596R e D594V hanno un effetto inibitorio dominante sulla funzione della mutazione V600E di BRAF 96
EFFETTO DI DUE INIBITORI CHINASICI IN LINEE CELLULARI DI CARCINOMA TIROIDEO: STUDI IN VITRO E IN VIVO 95
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 94
Germline BRAF mutations in Noonan, LEOPARD and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum 93
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. 92
Clinical prognosis in BRAF-mutated PTC 91
Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer. 90
Oncogeni e chirurgia della tiroide 89
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 88
Caratteristiche genetiche di una coorte di carcinomi papillari della tiroide raccolta in Umbria e loro significato clinico 88
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway 85
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 83
Synthesis of phosphatidylserine by base exchange in rat cerebellum and cortex 82
Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells 82
Search of RET/PTC rearrangement and BRAF and RAS mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of BRAF mutation and allowed to detect a new mutation of BRAF oncoprotein 81
Sunitinib inhibits the growth of thyroid tumor xenografts in mice by acting primarily on tumor angiogenesis 81
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation 81
Targeted molecular therapies in thyroid carcinoma. 79
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response 75
Classification of thyroid diseases using machine learning and Bayesian graph algorithms 66
L’INIBIZIONE DI IDO1 (INDOLEAMMINA 2,3-DIOSSIGENASI 1) RIDUCE LA PROLIFERAZIONE DELLE CELLULE FTC133 62
Inactivating D594V and G596R amino acid substitutions have a dominant inhibitory effect on the V600E activating mutation of BRAF. 58
Predictors of response to lenvatinib in advanced differentiated thyroid cancer: focus on the CONUT score 37
Totale 5.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022346 0 0 0 43 9 3 7 145 2 23 44 70
2022/2023740 61 147 7 77 62 68 0 40 246 1 26 5
2023/2024267 24 32 9 5 3 2 43 18 49 7 46 29
2024/2025742 15 67 68 20 73 33 6 64 140 40 146 70
2025/20261.575 110 116 68 168 188 134 237 80 225 134 58 57
2026/2027501 30 46 140 285 0 0 0 0 0 0 0 0
Totale 5.448